Using Signos mHealth Platform in Adults for Weight Management

NAActive, not recruitingINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

April 30, 2026

Conditions
Overweight and ObesityMetabolic SyndromeWeight Loss
Interventions
DEVICE

Signos System

The intervention involves the use of the Signos System, a combination of a proprietary software application with a continuous glucose monitor (CGM), to manage weight in overweight and obese adults.

OTHER

Standard Lifestyle Education

"In the Standard Lifestyle Education arm, participants receive conventional advice on diet and exercise, focusing on general healthy lifestyle habits to manage weight."

Trial Locations (5)

33161

Segal Trials, North Miami

77008

Helios Clinical Research, Houston

85028

Helios Clinical Research (Phoenix), Phoenix

94598

Diablo Clinical Research, Walnut Creek

98105

Seattle Clinical Research, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Lindus Health, Inc.

UNKNOWN

lead

Signos Inc

INDUSTRY

NCT06214221 - Using Signos mHealth Platform in Adults for Weight Management | Biotech Hunter | Biotech Hunter